Prof. Anat Mirelman

Prof. Anat Mirelman

Research work

The research in the Laboratory of Early Markers Of Neurodegeneration (LEMON) aims to identify measures from multi-domains that can detect the development of neurodegeneration. We assess genetic, biological, imaging, clinical and digital measures obtained from healthy adults, those with known diseases and those with risk for developing disease. The main project in the lab is "The Genetics in Parkinson's disease Project" a longitudinal project evaluating patients and family members with genetic mutations associated with PD.  As part of this project we also explore neural prodromal changes using MRI, fMRI, EEG and fNIRS and sleep changes collected in the home with wearable sensors with the aim of configuring a personal risk through multi sensitive and quantitative modalities. Complementing the aim of identifying markers of disease, we also study reserve capacity and resilience of brain function as mitigators for neurodegeneration.  
The lab is home to researchers from different backgrounds: clinical (MD's and health science), engineering and data scientists (Bio-medical, electrical, mathematics and statistics) and behavioral (neuropsychology and neuroscience). The lab is situated in Tel Aviv Medcial Center (Ichilov)

Areas of interest & scientific knowledge

Clinical Neuroscience

Cognitive Neuroscience

Imaging Research

Selected Publications
  • Maidan I, Droby A, Jacob Y, Giladi N, Hausdorff JM, Mirelman A. The neural correlates of falls: Alterations in large-scale resting-state networks in elderly fallers [published online ahead of print, 2020 May 22]. Gait Posture. 2020;80:56-61. 
    https://pubmed.ncbi.nlm.nih.gov/32485425/
     
  • Kozlovski T, Mitelpunkt A, Thaler A, et al. Hierarchical Data-Driven Analysis of Clinical Symptoms Among Patients With Parkinson's Disease. Front Neurol. 2019;10:531. Published 2019 May 21. doi:10.3389/fneur.2019.00531
    https://pubmed.ncbi.nlm.nih.gov/31164863/
     
  • Mirelman A, Saunders-Pullman R, Alcalay RN, et al. Application of the Movement Disorder Society prodromal criteria in healthy G2019S-LRRK2 carriers. Mov Disord. 2018;33(6):966-973. doi:10.1002/mds.27342
    https://pubmed.ncbi.nlm.nih.gov/29603409/
     
  • Mirelman A, Maidan I, Bernad-Elazari H, Shustack S, Giladi N, Hausdorff JM. Effects of aging on prefrontal brain activation during challenging walking conditions. Brain Cogn. 2017;115:41-46. doi:10.1016/j.bandc.2017.04.002
    https://pubmed.ncbi.nlm.nih.gov/28433922/
     
  • Hausdorff JM, Hillel I, Shustak S, et al. Everyday Stepping Quantity and Quality Among Older Adult Fallers With and Without Mild Cognitive Impairment: Initial Evidence for New Motor Markers of Cognitive Deficits?. J Gerontol A Biol Sci Med Sci. 2018;73(8):1078-1082. 
    https://pubmed.ncbi.nlm.nih.gov/29394317/
Tel Aviv University makes every effort to respect copyright. If you own copyright to the content contained
here and / or the use of such content is in your opinion infringing Contact us as soon as possible >>